Multiple Choice
A pharmaceutical researcher develops a therapy to treat a protein misfolding disorder. Specifically, a mutation in this disorder leads to abnormal protein folding and subsequent intracellular degradation of the protein before it can reach the cell membrane. With the new combination drug therapy, the first drug corrects the processing and trafficking of the protein, enabling it to reach the cell surface membrane. Once the protein has reached the cell surface, its function is enhanced by the second drug. This therapy is most likely to be helpful in which of the following conditions?
A) Alzheimer disease
B) Creutzfeldt-Jakob disease
C) Cystic fibrosis
D) Phenylketonuria
E) Sickle cell anemia
Correct Answer:

Verified
Correct Answer:
Verified
Q27: A 4-year-old boy is brought to the
Q28: A 1-hour-old girl born to a 40-year-old
Q29: A 40-year-old woman, gravida 5, para 0,
Q30: A healthy couple, who recently emigrated from
Q31: A 16-year-old girl with a history of
Q33: A study is undertaken to map the
Q34: A 1-day-old infant in the newborn nursery
Q35: A 26-year-old woman comes to the office
Q36: A pharmaceutical corporation investigating new therapeutic agents
Q37: A pharmaceutical researcher develops a new drug